Abstract
The development of clinical trial protocols for testing safety and efficacy of therapeutic interventions requires the blending of traditional methodologies with special consideration of the indications. The specificity of disease definition, precise identification of target populations, study design rationales, instruments, and selection of endpoints all contribute to the difficulty of conducting successful trials in this arena. An understanding of these issues can lead to improved clinical protocols.